# Effect of Whole-Body Vibration on Plasma Sclerostin Level

> **NCT01310335** · NA · COMPLETED · sponsor: **Bagcilar Training and Research Hospital** · enrollment: 15 (actual)

## Conditions studied

- Osteopenia

## Interventions

- **DEVICE:** whole-body vibration (WBV)

## Key facts

- **NCT ID:** NCT01310335
- **Lead sponsor:** Bagcilar Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01310335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01310335, "Effect of Whole-Body Vibration on Plasma Sclerostin Level". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01310335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
